Clinical Study
Silver-Coated Hip Megaprosthesis in Oncological Limb Savage Surgery
Table 1
Main characteristics of the analyzed population. The two groups were homogeneous for the considered parameter.
| | | Uncoated prosthesis | Silver-coated prosthesis | Overall population |
| | Number of patients (male : female) | 30 (14 M : 16 F) | 38 (17 M : 21 F) | 68 (31 M : 37 F) | | Age at first surgery | 60.1 y (23–75 y) | 62.8 y (21–78 y) | 61.6 y (21–78 y) | | Primary bone tumor (PBT) : metastatic lesion (ML) | 9 PBT : 21 ML | 14 PBT : 24 ML | 23 PBT : 45 ML | | Bone resection size (cm) | 14.7 cm (12–22 cm) | 18.3 cm (12–28 cm) | 16.7 cm (12–28 cm) | | Use of Trevira Tube | 93.3% | 94.7% | 94.2% | | Follow-up (months) | 51.2 (12–114 months) | 42.8 (12–97 months) | 46.5 (12–114 months) | | Death (time of death) | 20.0% (34.7 months) | 18.4% (35.8 months) | 19.2% (35.3 months) | | Complications requiring surgery | 7 (23.3%) | 7 (18.4%) | 14 (20.6%) |
|
|
